VICTOR AMOBI: Open Payments
NPI 1356532386 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 8 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $466 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $153 |
| Alkermes, Inc. | 2 | $150 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Corium, LLC | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
Products named: INGREZZA, ARISTADA, ABILIFY MAINTENA, LYBALVI, Azstarys, UZEDY.
Industry payments across NY — which companies pay providers there.
